Patent details

Basic Information

Publication number:

EP3514151

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP191601244

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PROTEIN KINASE C INHIBITORS AND METHODS OF THEIR USE

French Title of Invention:

INHIBITEURS DE PROTÉINE KINASE C ET LEURS PROCÉDÉS D'UTILISATION

German Title of Invention:

PROTEINKINASE-C-HEMMER UND VERFAHREN ZU DEREN VERWENDUNG

SPC Number:

Dates

Filing date:

05/08/2015

Grant date:

23/04/2025

EP Publication Date:

24/07/2019

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/04/2025

EP B1 Publication Date:

23/04/2025

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

05/08/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/04/2025

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

VISSER, Michael Scott

Address:

United States (US)

2

Name:

PAPILLON, Julien

Address:

United States (US)

3

Name:

LUZZIO, Michael Joseph

Address:

United States (US)

Priority

Priority Number:

201462033679 P

Priority Date:

06/08/2014

Priority Country:

United States (US)

Classification

IPC classification:

C07D 401/14; C07D 413/14; A61K 31/506; A61P 31/04; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

202517

Publication date:

23/04/2025

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

01/09/2025

Annual Fee Number:

11

Annual Fee Amount:

148 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages